CA Patent

CA2832570A1 — New intermediates and processes for preparing ticagrelor

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2012-10-11 · 14y expired

What this patent protects

The present invention is related to new intermediates and processes for preparing Ticagrelor disclosed in this patent application.

USPTO Abstract

The present invention is related to new intermediates and processes for preparing Ticagrelor disclosed in this patent application.

Drugs covered by this patent

Patent Metadata

Patent number
CA2832570A1
Jurisdiction
CA
Classification
—
Expires
2012-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Teva Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.